老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Galmed Pharmaceuticals Ltd.

0.5881
-0.0119-1.98%
成交量：6,275.00
成交额：3,724.49
市值：387.05万
市盈率：-0.17
高：0.6040
开：0.6040
低：0.5851
收：0.6000
52周最高：2.68
52周最低：0.5025
股本：658.14万
流通股本：650.57万
量比：0.18
换手率：0.10%
股息：- -
股息率：- -
每股收益(TTM):-3.4400
每股收益(LYR):-8.0757
净资产收益率：-46.34%
总资产收益率：-20.90%
市净率：0.20
市盈率(LYR):-0.07

数据加载中...

总览公司新闻资讯公告
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多